News
Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN (NYSE: ...
7h
Medical Device Network on MSNBiocartis’ EGFR Mutation Test gains IVDR Class C CDx certificationBiocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System ...
8h
Barchart on MSNAbbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.
CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry's first fully-transparent machine ...
Scientists at the Liverpool School of Tropical Medicine (LSTM) have developed a more precise diagnostic tool to distinguish ...
NEW YORK — Genedrive said on Friday that it has received CE marking under the EU's In Vitro Diagnostic Medical Device Regulation (IVDR) for its point-of-care CYP2C19 ID Kit genotyping platform, which ...
Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...
Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of ...
The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...
4d
Medical Device Network on MSNIllumina widens access to cancer tests with Medicare and new CDxIllumina’s TSO Comprehensive IVD test and two companion diagnostic (CDx) indications secured approval from the FDA last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results